Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Flow cytometric BrdU/DNA assay for anticancer agent sensitivity test].

N Katayanagi1, T Suzuki, O Tanaka

  • 1First Department of Surgery, Niigata University School of Medicine.

Nihon Rinsho. Japanese Journal of Clinical Medicine
|October 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A gross anatomical study of the styloid process of the temporal bone in Japanese cadavers.

Folia morphologica·2021
Same author

Variations in the gonadal artery with a single common trunk: embryological hypotheses by observation.

Folia morphologica·2020
Same author

Majorana quantization and half-integer thermal quantum Hall effect in a Kitaev spin liquid.

Nature·2018
Same author

Variations of the cephalic vein anterior to the clavicle in humans.

Folia morphologica·2018
Same author

Common and separate origins of the left and right inferior phrenic artery with a review of the literature.

Folia morphologica·2017
Same author

Anomalous connection of the left posterior renal vein with the left ascending lumbar vein in a Japanese cadaver.

Folia morphologica·2015
Same journal

[Development of novel therapeutics for multiple myeloma and improvement of drug lag].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Clinical pharmacy services to patients of immunomodulatory drugs].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Therapeutic drug monitoring of the new anti-myeloma drugs in the treatment of multiple myeloma].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Prognostic value of minimal residual disease assessment using next-generation sequencing in multiple myeloma].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[The evaluation of minimal residual disease in multiple myeloma by an allele-specific oligonucleotide real-time PCR].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Evaluation of minimal residual disease in myeloma by multiparametric flow cytometry].

Nihon rinsho. Japanese journal of clinical medicine·2019
See all related articles

The BrdU/DNA double staining method using flow cytometry effectively predicts anticancer drug efficacy. This chemosensitivity test correlates with cell death, aiding in selecting optimal cancer treatments.

Area of Science:

  • Cell Biology
  • Pharmacology
  • Oncology

Context:

  • Assessing anticancer agent efficacy is crucial for personalized cancer therapy.
  • Traditional chemosensitivity tests can be time-consuming and lack precision.
  • Developing rapid and reliable methods to predict drug response is essential.

Purpose:

  • To evaluate the BrdU/DNA double staining method combined with flow cytometry as a chemosensitivity test for anticancer agents.
  • To correlate the changes in G2 phase fraction and BrdU labeling index with the lethal effects of chemotherapy.
  • To explore the clinical applicability of this assay for selecting effective anticancer drugs.

Summary:

  • The BrdU/DNA double staining method using flow cytometry was investigated as a chemosensitivity test.

Related Experiment Videos

  • Experimentally, cisplatin (CDDP), adriamycin (ADM), and mitomycin C (MMC) significantly increased G2 phase fraction and decreased the BrdU labeling index.
  • These changes correlated well with colony formation assays, indicating their utility in assessing anticancer agent lethality.

    • Impact:

    • The BrdU/DNA assay provides a reliable method for evaluating anticancer drug effectiveness.
    • Clinical application is feasible using enzymatic preparation and Ficoll density gradient for viable tumor cell collection.
    • This flow cytometric assay can guide clinical decisions in selecting appropriate anticancer drugs for individual patients.